C
Catalyst Pharmaceuticals, Inc. (CPRX)
NCM – Real vaqt narxi. Valyuta: USD
31.14
-0.01 (-0.03%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
31.14
-0.01 (-0.03%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Catalyst Pharmaceuticals, Inc., tijorat bosqichidagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda kam uchraydigan kasalliklari bo'lgan bemorlar uchun dori vositalarini ishlab chiqish va tijoratlashtirishga qaratilgan. U lambert-eaton miyastenik sindromi (LEMS) bilan og'rigan bemorlarni davolash uchun Firdapse; fokal boshlanuvchi tutqanoqlarni, shuningdek tonik-klonik tutqanoqlarni davolash uchun ishlatiladigan postsinaptik ionotrop alfa-amino-3-gidroksi-5-metil-4-izoksazolpropion kislotasi glutamat retseptorining yangi, raqobatchi bo'lmagan selektiv antagonistini Fycompa; va Duchenne mushak distrofiyasini davolash uchun kortikosteroid bo'lgan AGAMREEni taklif etadi. Kompaniya BioMarin Pharmaceutical Inc. bilan litsenziyalash shartnomalariga; va jenerik Sabril planshetlarini ishlab chiqish va tijoratlashtirish bo'yicha Endo Ventures Limited bilan hamkorlik va litsenziyalash shartnomasiga ega. Catalyst Pharmaceuticals, Inc. 2002 yilda tashkil etilgan va Coral Gables, Florida shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Preethi Sundaram Ph.D. | Chief Strategy Officer |
| Dr. Steven R. Miller Ph.D. | Executive VP, COO & Chief Scientific Officer |
| Dr. William T. Andrews FACP, M.D. | Chief Medical Officer |
| Mr. Brian Elsbernd J.D. | Chief Compliance Officer & Chief Legal Officer |
| Mr. Gregg Russo | Chief Human Resources Officer |
| Mr. Jeffrey Del Carmen | Executive VP & Chief Commercial Officer |
| Mr. Michael W. Kalb CPA | Executive VP, Treasurer & CFO |
| Mr. Patrick J. McEnany | Co-Founder & Non-Executive Chairman |
| Mr. Richard John Daly M.B.A. | President, CEO & Director |
| Ms. Mary Coleman | VP & Head of Investor Relations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-11 | 8-K | d845745d8k.htm |
| 2026-05-08 | DEFA14A | d112057ddefa14a.htm |
| 2026-05-07 | DEFA14A | d141405ddefa14a.htm |
| 2026-05-07 | 8-K | d90722d8k.htm |
| 2026-04-30 | 10-K/A | d134396d10ka.htm |
| 2026-03-19 | 8-K/A | d25173d8ka.htm |
| 2026-03-18 | 8-K | d111324d8k.htm |
| 2026-02-25 | 8-K | d108222d8k.htm |
| 2026-02-25 | 10-K | cprx-20251231.htm |
| 2026-01-12 | 8-K | d62132d8k.htm |